This document is an amendment to the Series B Convertible Preferred Stock Purchase Agreement between Foundation Medicine, Inc. and various investors, including Gates Ventures, LLC. It outlines the terms for the sale and issuance of additional shares of Series B Preferred Stock, the conditions for closing, and the rights and obligations of the parties involved.
documents/EFTA01143305.pdf
{}